7.55
price down icon8.37%   -0.69
pre-market  Vorhandelsmarkt:  7.60   0.05   +0.66%
loading
Schlusskurs vom Vortag:
$8.24
Offen:
$8.06
24-Stunden-Volumen:
44,737
Relative Volume:
0.12
Marktkapitalisierung:
$15.30M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-25.56M
KGV:
-1.4519
EPS:
-5.2
Netto-Cashflow:
$-19.35M
1W Leistung:
-6.21%
1M Leistung:
+605.61%
6M Leistung:
+291.19%
1J Leistung:
+85.41%
1-Tages-Spanne:
Value
$7.38
$8.3988
1-Wochen-Bereich:
Value
$7.24
$9.09
52-Wochen-Spanne:
Value
$0.62
$9.56

Biovie Inc Stock (BIVI) Company Profile

Name
Firmenname
Biovie Inc
Name
Telefon
775-888-3162
Name
Adresse
680 W NYE LANE, CARSON CITY
Name
Mitarbeiter
14
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
BIVI's Discussions on Twitter

Vergleichen Sie BIVI mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
BIVI
Biovie Inc
7.55 15.30M 0 -25.56M -19.35M -5.20
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Biovie Inc Stock (BIVI) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2022-07-22 Eingeleitet Cantor Fitzgerald Overweight
2021-01-15 Eingeleitet B. Riley Securities Buy

Biovie Inc Aktie (BIVI) Neueste Nachrichten

pulisher
Jul 24, 2025

What drives BioVie Inc. stock priceUnprecedented market success - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Is BioVie Inc. stock overhyped or has real potentialTremendous wealth creation - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Biovie shares climb as Alzheimer’s drug shows promising age deceleration effects - MSN

Jul 24, 2025
pulisher
Jul 24, 2025

Biovie stock rises after drug shows age deceleration in Alzheimer’s patients - Investing.com Australia

Jul 24, 2025
pulisher
Jul 24, 2025

BioVie presents data on Bezisterim at WCAG-2025 - TipRanks

Jul 24, 2025
pulisher
Jul 24, 2025

BioVie Inc. Presents Promising Phase 3 Study Results for Bezisterim in Alzheimer’s Disease at WCAG-2025 - Quiver Quantitative

Jul 24, 2025
pulisher
Jul 24, 2025

Breakthrough: New Alzheimer's Drug Bezisterim Reverses Aging Across 10 Biological Markers, Trial Data Reveals - Stock Titan

Jul 24, 2025
pulisher
Jul 23, 2025

BioVie Expands Board Amid Drug Development Momentum - TipRanks

Jul 23, 2025
pulisher
Jul 23, 2025

Is BioVie Inc. a good long term investmentRobust investment performance - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

BioVie Inc. Stock Analysis and ForecastConsistently exceptional gains - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

BioVie appoints Amy Chappell, Kameel Farag to board of directors - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

BioVie Inc. Appoints Dr. Amy S. Chappell and Kameel D. Farag to Board of Directors - Quiver Quantitative

Jul 22, 2025
pulisher
Jul 22, 2025

BioVie Appoints Industry Veterans Amy Chappell, MD, FAAN, and Kameel Farag to Board of Directors - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about BioVie Inc. stockExceptional trading results - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

New to The Street Episode #679 Airs Tonight on Fox Business Network - New Castle News

Jul 21, 2025
pulisher
Jul 20, 2025

What makes BioVie Inc. stock price move sharplyFree Consultation - beatles.ru

Jul 20, 2025
pulisher
Jul 19, 2025

How high can BioVie Inc. stock price go in 2025Free Stock Market Practical Discussion Forums - beatles.ru

Jul 19, 2025
pulisher
Jul 15, 2025

Why BioVie Inc. stock attracts strong analyst attentionFree Real-Time Market Predictions - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How BioVie Inc. stock performs during market volatilityRisk Aware High Growth Picks - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

New to The Street Episode #678 to Air on Bloomberg TV Featuring Game-Changing Innovators in AI, Biotech, Blockchain, and Sustainability - The Des Moines Register

Jul 12, 2025
pulisher
Jul 09, 2025

BioVie Inc. Presents Promising Data on Bezisterim's Effects on Aging and Neurodegeneration at World Aging and Rejuvenation Conference - Nasdaq

Jul 09, 2025
pulisher
Jul 09, 2025

BioVie Announces Data Highlighting Bezisterim’s Potential to Slow or Reverse Biological Aging and Neurodegeneration Featured as a Keynote Talk at the 7th World Aging and Rejuvenation Conference - The Manila Times

Jul 09, 2025
pulisher
Jul 09, 2025

Breakthrough Alzheimer's Drug Shows Unprecedented 4-Year Biological Age Reversal in Phase 3 Trial - Stock Titan

Jul 09, 2025
pulisher
Jul 08, 2025

BioVie (NASDAQ:BIVI) Stock Price Down 15.6% – Should You Sell? - Defense World

Jul 08, 2025
pulisher
Jul 03, 2025

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of BioVie Inc. (BIVI) - ACCESS Newswire

Jul 03, 2025
pulisher
Jul 01, 2025

BioVie To Carry Out 1-for-10 Reverse Stock Split On July 7th, 2025 - 富途牛牛

Jul 01, 2025
pulisher
Jun 27, 2025

BioVie Announces 1-for-10 Reverse Stock Split - TipRanks

Jun 27, 2025
pulisher
Jun 27, 2025

New to The Street Announces the Broadcast of Show Number 675 This Saturday at 6:30 PM EST on Bloomberg Television Featuring: FLOKI, BioVie (NASDAQ: BIVI), Arrive AI ($ARAI), Health In Tech (NASDAQ HIT), and Commercialville T.V. - Foster's Daily Democrat

Jun 27, 2025
pulisher
Jun 27, 2025

BioVie (BIVI) Highlights Innovative Clinical Trial at Upcoming C - GuruFocus

Jun 27, 2025
pulisher
Jun 27, 2025

New to The Street Show Number 675 Airing This Saturday on Bloomberg Television Featuring FLOKI, BioVie, Arrive AI, Health In Tech, and Commercialville T.V. - AInvest

Jun 27, 2025
pulisher
Jun 26, 2025

BioVie announces poster on patient-centric accessibility of SUNRISE-PD trial - TipRanks

Jun 26, 2025
pulisher
Jun 26, 2025

Revolutionary Parkinson's Trial Brings Treatment Testing to Patients' HomesSee How It Works - Stock Titan

Jun 26, 2025

Finanzdaten der Biovie Inc-Aktie (BIVI)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Kapitalisierung:     |  Volumen (24h):